2 strong blue chip ASX shares rated as buys by brokers

These 2 blue chip ASX shares are rated as buys by brokers. One of those ideas is biotech healthcare giant CSL Limited (ASX:CSL).

| More on:
best fintech asx shares represented by businessman flexing biceps

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Blue chip ASX shares can make good investments and some brokers have been scouring the market for the best ones to own.

The idea is that the broker will try to find the opportunities that might do well over the next 12 months – so then a price target is assigned. The bigger the price target, the stronger the return might be over the next year.

These two blue chip ASX shares are ones that leading brokers like:

CSL Limited (ASX: CSL)

CSL is actually one of the biggest blue chip shares on the ASX. It has a market capitalisation well over $100 billion.

One of the brokers that likes the CSL share price right now is UBS. Whilst the interim report was strong, the broker doesn't think the following six months will be as good.

A key reason for the weaker expectation is that plasma collections are suffering and may not turn around until near the end of FY21.

One of the things that may help CSL is when COVID-19 vaccines have been deployed. However there is a while to go with this.

The blue chip ASX share is reporting some strength in its Seqirus business which CSL said delivered an exceptionally strong performance in the first six months of the financial year.

CSL did say that its performance is being supported by its diversified and resilient business model.

In the first half of FY21 it made $1.81 billion of net profit after tax (NPAT). Full year profit for FY21 is expected to be between $2.17 billion to $2.265 billion, which would be growth of up to 8% in constant currency terms, despite all of the impacts.

UBS has a price target of $310 for CSL shares, which would be growth of almost 30%.

Fortescue Metals Group Limited (ASX: FMG)

Fortescue is now one of the world's biggest iron ore miners and it's still rated as a buy by the brokers at Macquarie Group Ltd (ASX: MQG).

The blue chip ASX share is benefiting from the high iron ore prices and this is sending the net profit surging higher.

In the FY21 half-year result, revenue jumped 44% to $9.3 billion, underlying earnings before interest, tax, depreciation and amortisation (EBITDA) rose 57% to $6.6 billion and net profit after tax grew 66% to $4.08 billion. This funded a 93% increase of the dividend to AU$1.47 per share.

Fortescue has announced it plans to shift its business to greener initiatives sooner than expected with a goal of being carbon neutral by 2030.

Some of the plans include green hydrogen, renewable energy and green ammonia. It's looking for these types of projects across Australia and the world. Fortescue is looking to reduce its own footprint with getting rid of diesel consumption.

Macquarie doesn't think that FY22 will be as strong as FY21. So, for FY22, Macquarie is predicting that Fortescue can generate $2.42 of earnings per share (EPS) and that it's going to pay a dividend of $1.94 per share. That would translate into a forward grossed-up dividend yield of 13.6%. Macquarie has a price target of $25.50 for Macquarie. 

Tristan Harrison owns shares of Fortescue Metals Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Blue Chip Shares

A once-in-a-decade opportunity to buy CSL shares?

This biotech giant could have major upside potential in 2026.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Blue Chip Shares

Top Australian stocks to buy with $2,000 right now

Let's see why these top stocks could be great destinations for your hard-earned money.

Read more »

a woman sits in comtemplation with superimposed images of piles of gold coins, graphs and star-like lights above her head as though she is thinking about investment options.
Blue Chip Shares

If I invest $15,000 in Macquarie shares, how much passive income will I receive in 2026?

Is Macquarie a great option for dividend income?

Read more »

The word growth with bles arrows shooting up above it, indicating a share price movement for ASX growth stocks
Blue Chip Shares

2 great ASX 200 blue-chip shares I'd buy right now!

These industry-leading businesses look much better value today.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Blue Chip Shares

The outstanding Australian shares I'd be happy owning forever

Let's see why these shares could be worthy of a spot in your investment portfolio.

Read more »

A woman uses her mobile phone to make a purchase.
Blue Chip Shares

Why I think Telstra shares are a strong blue-chip buy

Telstra is built for stability, not hype. Its recurring revenue and defensive qualities give it a clear role in long-term…

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
Blue Chip Shares

3 ASX 200 blue chip shares built for the long term

These blue chips could be destined for big things in the future.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Blue Chip Shares

Should you buy Wesfarmers shares before February?

With earnings season approaching, investors may be weighing whether Wesfarmers’ recent pullback presents a buying opportunity.

Read more »